30 Jan, EOD - Indian

SENSEX 76759.81 (0.30)

Nifty 50 23249.5 (0.37)

Nifty Bank 49311.95 (0.30)

Nifty IT 42426.65 (-1.14)

Nifty Midcap 100 52714.25 (-0.01)

Nifty Next 50 62193.15 (0.08)

Nifty Pharma 21419.65 (1.21)

Nifty Smallcap 100 16560.5 (0.12)

30 Jan, EOD - Global

NIKKEI 225 39540.37 (0.07)

HANG SENG 20225.11 (0.14)

S&P 6126.25 (0.25)

LOGIN HERE

companylogoJyothy Labs Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 532926 | NSE Symbol : JYOTHYLAB | ISIN : INE668F01031 | Industry : FMCG |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
15-Jan-2025 31-Jan-2025 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2024, with limited review thereon by the Statutory Auditors of the Company.
04-Nov-2024 12-Nov-2024 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and half year ended September 30 2024 with limited review thereon by the Statutory Auditors of the Company Unaudited Financial Results For The quarter and half year ended September 30, 2024 (As Per BSE Announcement Dated on 12.11.2024)
09-Jul-2024 25-Jul-2024 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter ended June 30 2024 with limited review thereon by the Statutory Auditors of the Company Outcome of Board Meeting held on July 25, 2024 (As per BSE Announcement Dated on 25/07/2024)
03-May-2024 15-May-2024 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 inter alia to consider and approve the Audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and year ended March 31 2024 together with the Auditors Reports thereon by the Statutory Auditors of the Company; and recommend dividend if any on the equity shares of the Company for the financial year 2023-24. The Board of Directors at its meeting held on May 15, 2024 recommended final dividend of Rs. 3.50/- per equity share of Re. 1/- each, subject to the approval of the shareholders. Appointment of Chairperson (As Per BSE Announcement Dated on 15/05/2024)
12-Jan-2024 31-Jan-2024 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31 2023 with limited review thereon by the Statutory Auditors of the Company. Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023 Intimation under Regulation 30 read with Part A of Schedule IIII of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding changes in Directorship of the Company (As Per BSE Announcement Dated on: 31/01/2024)
24-Nov-2023 24-Nov-2023 Change in Directors Pursuant to Regulation 30(2) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today, accepted the resignation of Ms. M. R. Deepthi (DIN: 01746698) as Whole Time Director, Director and Employee of the Company with effect from November 24, 2023
30-Oct-2023 07-Nov-2023 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and half year ended September 30 2023 with limited review thereon by the Statutory Auditors of the Company Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023 (As Per BSE Announcement Dated on 07.11.2023)
14-Jul-2023 25-Jul-2023 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2023 inter alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter ended June 30 2023 with limited review thereon by the Statutory Auditors of the Company. Results - Financial Results for June 30, 2023 Board Meeting Outcome For Financial Results For The Quarter Ended June 30, 2023 (As Per BSE Announcement Dated on 25.07.2023)
09-Jun-2023 09-Jun-2023 Employee Stock Option The Board of Directors of the Company approved, formulation of Employee Stock Option Scheme, viz., Jyothy Labs Limited - Restricted Stock Unit Plan 2023, in terms of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
25-Apr-2023 03-May-2023 Accounts Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2023 inter alia to consider and approve Board Meeting to consider and approve the Audited Financial Results for the quarter and year ended March 31 2023 and consider recommendation of dividend if any on the equity shares of the Company for the financial year 2022-23 Audited Results & Final Dividend (As per BSE Bulletin dated on 25/04/2023) Audited Financial Results for the quarter and year ended March 31, 2023 Outcome of the Board Meeting held on May 3, 2023 The Register of Member and Share Transfer Books of the Company will remain closed from Tuesday, July 4, 2023 to Tuesday, July 11, 2023 (both days inclusive) for taking record of the members of the Company who are eligible for the purpose of payment of dividend and for the 32nd Annual General Meeting of the Company Re-appointment of Ms. Bhumika Batra as an Independent Director of the Company for a second consecutive term of 5 years commencing from March 14, 2024 up to March 13, 2029 (both days inclusive), subject to the approval of members at the ensuing Annual General Meeting of the Company (As Per BSE Announcement dated on 03.05.2023)
17-Jan-2023 25-Jan-2023 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 inter alia to consider and approve Meeting of the Board of Directors of Jyothy Labs Limited is scheduled to be held on Wednesday January 25 2023 inter-alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31 2022 with limited review thereon by the Statutory Auditors of the Company The Board approved the Un-audited Financial Results on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2022 with Limited Review by the Statutory Auditors of the Company (As per BSE Announcement Dated on 25/01/2023) Newspaper publication - Un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2022 (As Per BSE Announcement Dated on 27/01/2023)
04-Nov-2022 14-Nov-2022 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a Meeting of the Board of Directors of Jyothy Labs Limited is scheduled to be held on Monday November 14 2022 inter-alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and half year ended September 30 2022 with limited review thereon by the Statutory Auditors of the Company Results - Financial Results for the quarter and half year ended September 30, 2022 (As Per BSE Announcement Dated on 14.11.2022)
15-Jul-2022 25-Jul-2022 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on Monday July 25 2022 Unaudited Financial Results for quarter ended June 30, 2022 (As per BSE Announcement Dated on 25/07/2022)
16-May-2022 24-May-2022 Final Dividend Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on Tuesday May 24 2022 Equity Rs.2.5000 per share(250%)Final Dividend (As Per BSE Bulletin Dated on 24.05.2022) Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2022 Outcome of the Board Meeting held on May 24, 2022 (As per BSE Announcement Dated on 24/5/2022)
12-Jan-2022 21-Jan-2022 Quarterly Results Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2022 inter alia to consider and approve Board Meeting to consider and approve the Unaudited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31 2021 with limited review thereon by the Statutory Auditors of the Company The Board of Directors of the Company approved the Un-audited Financial Results on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2021 with Limited Review by the Statutory Auditors of the Company (As Per BSE Announcement Dated on 21.01.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +